Abnehmen in den Wechseljahren
Wechseljahre – Tipps zur Ernährung
Referenzen
1 Seifert-Klauss, V., Menopause – Menopause Gesellschaft (menopause-gesellschaft.de). https://www.menopause-gesellschaft.de/themen/menopause/ (Stand: 12.02.2024)
2 WHO. Menopause. Fact sheet. 2022 Oct 17. https://www.who.int/news-room/fact-sheets/detail/menopause (Stand: 16.01.2024).
3 Davis, SR., et al. Understanding weight gain at menopause. Climacteric. 2012 Oct;15(5):419-29.
4 gesund.bund.de. Gesund leben. Gesund älter werden: Mit guter Ernährung und viel Bewegung. https://gesund.bund.de/ernaehrung-und-bewegung-im-alter (Stand. 10.01.2024).
5 Thurston RC. et al. Gains in body fat and vasomotor symptom reporting over the menopausal transition: the Study of Women’s Health across the Nation. Am J Epidemiol 2009;170:766–74.
6 Fernández-Alonso, AM. et al. Obesity is related to increased menopausal symptoms among Spanish women. Menopause Int 2010;16:105–10.
7 Chedraui, P. et al. Menopausal symptoms and associated risk factors among postmenopausal women screened for the metabolic syndrome. Arch Gynecol Obstet 2007;275:161–8.
8 Huang, AJ. et al. An intensive behavioral weight loss intervention andhot flushes in women. Arch Intern Med 2010;170:1161–7.
9 Rondanelli, M. et al. (2023). A randomized double-blind placebo-controlled clinical study to evaluate the e ect on the weight of a medical device with polyglucosamine L112 in a group of overweight and obese subjects. Nutrients, 15(16), 3516.
10 Cnubben, N. H. et al. A single oral dose of a polyglucosamine influences the bioavailability of [9-(14)C]-Oleic acid in adult female Gottingen minipigs. BMC Obes 3, 18, (2016).
11 Cornelli, U. et al. Long-Term Treatment of Overweight and Obesity with Polyglucosamine (PG L112): Randomized Study Compared with Placebo in Subjects after Caloric Restriction. Curr Dev Nutr 1, e000919, (2017).